|
| Press Releases |
|
 |
|
| Monday, August 27, 2018 |
|
|
Dah Chong Hong Announces 2018 Interim Results |
| Dah Chong Hong Holdings Limited ("DCH"; stock code: 1828.HK) announced today its results for the half year ended 30 June 2018. more info >> |
|
| Thursday, March 8, 2018 |
|
|
Dah Chong Hong Announces 2017 Annual Results |
| Dah Chong Hong Holdings Limited ("DCH" or the "Group"; stock code: 01828) announced today its results for the year ended 31 December 2017. more info >> |
|
| Monday, January 22, 2018 |
|
|
DCH issues positive profit alert announcement |
| Dah Chong Hong Holdings Limited ("DCH", HKSE: 1828) announced today that based on a preliminary review of the unaudited financial information of the Group, DCH expects to record an increase of more than 50% in its consolidated net profit attributable to shareholders for the year ended 31 December 2017 as compared to the year ended 31 December 2016. more info >> |
|
| Wednesday, March 2, 2011 |
|
|
大昌行宣布二零一零年全年业绩，飞跃增长 再创新高 |
| 大昌行集团有限公司今日宣布其截至二零一零年十二月三十一日止年度的总营业额为港币三百二十二亿一千一百万元，较去年增加45.0% (二零零九年：港币二百二十二亿零九百万元)。 more info >> |
|
|
大昌行宣佈二零一零年全年業績，飛躍增長 再創新高 |
| 大昌行集團有限公司今日宣佈其截至二零一零年十二月三十一日止年度的總營業額為港幣三百二十二億一千一百萬元，較去年增加45.0%。股東應佔溢利為港幣十四億一千一百萬元，較二零零九年的港幣七億一千萬元上升了98.7%。 more info >> |
|
|
Dah Chong Hong Announces 2010 Annual Results; Record Year on the Fast Track - High Growth Accelerates |
| Dah Chong Hong Holdings announced today that it recorded total turnover of HK$32,211 million for the year ended 31 December 2010, an increase of 45.0% against the previous year, and profit attributable to shareholders of HK$1,411 million, up by 98.7% compared to HK$710 million in 2009. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Everest Medicines Unveils 2030 Strategy as Directors and Substantial Shareholder Buy Over HKD 38 Million of Shares
Dec 16, 2025 11:47 HKT/SGT
|
|
|
青島國資+雙管線驅動！華芢生物（02396.HK）破局PDGF稀缺賽道 錨定國配核心機遇
Dec 16, 2025 10:39 HKT/SGT
|
|
|
青岛国资+双管线驱动！华芢生物（02396.HK）破局PDGF稀缺赛道 锚定国配核心机遇
Dec 16, 2025 10:39 HKT/SGT
|
|
|
康哲藥業（867.HK/8A8.SG）：創新藥口服JAK1抑制劑Povorcitinib在中國獲納入「突破性治療品種」
Dec 16, 2025 08:07 HKT/SGT
|
|
|
康哲药业（867.HK/8A8.SG）：创新药口服JAK1抑制剂Povorcitinib在中国获纳入"突破性治疗品种"
Dec 16, 2025 08:06 HKT/SGT
|
|
|
SAKENOVA: 28-Year-Old Master Brewer Pioneers AI-Driven Sake Revolution, Achieving 40% Cost Reduction While Winning International Gold Medals
Dec 15, 2025 23:00 JST
|
|
|
GMG Unveils Graphene Aluminium-Ion Battery That Fully Charges in 6 Minutes
Dec 15, 2025 21:09 HKT/SGT
|
|
|
CMS (867.HK/8A8.SG): Innovative Drug Oral JAK1 Inhibitor Povorcitinib Has Been Included in the List of Breakthrough Therapeutic Drugs in China
Dec 15, 2025 21:00: JST
|
|
|
CMS (867.HK/8A8.SG): Innovative Drug Oral JAK1 Inhibitor Povorcitinib Has Been Included in the List of Breakthrough Therapeutic Drugs in China
Dec 15, 2025 21:00 HKT/SGT
|
|
|
NEC Provides Vehicle Management Equipment for Autonomous Driving at Tokyo International Airport
Dec 15, 2025 19:41 JST
|
|
|
希迪智駕招股進行中：構築智能駕駛產業化底座 多場景落地打開成長空間
Dec 15, 2025 18:06 HKT/SGT
|
|
|
希迪智驾招股进行中：构筑智能驾驶产业化底座 多场景落地打开成长空间
Dec 15, 2025 18:06 HKT/SGT
|
|
|
NEC and AEROTHAI Elevate Air Traffic Safety with Advanced Time Sync Solutions from Adtran Oscilloquartz
Dec 15, 2025 19:04 JST
|
|
|
Everest Medicines Unveils 2030 Strategy as Directors and Substantial Shareholder Buy Over HKD 38 Million of Shares
Dec 15, 2025 17:59: JST
|
|
|
雲頂新耀發佈2030戰略規劃 管理層及主要股東增持超3800萬港元股份
Dec 15, 2025 16:59 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
